Anavex Life Sciences (AVXL) Short-term Investments (2018 - 2019)
Anavex Life Sciences' (AVXL) quarterly Short-term Investments came in at $15000.0 in Q2 2019, little changed quarter-over-quarter from $15000.0 in Q1 2019.
Anavex Life Sciences (AVXL) Short-term Investments (2018 - 2019) Analysis & Trends
Anavex Life Sciences has disclosed Short-term Investments across 2 years of filings, most recently posting $15000.0 for Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Anavex Life Sciences | 221.68 Mn | 89.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | 43,047.00 |